Socioeconomic inequality in the use of prescription medications for smoking cessation among patients with COPD: a nationwide study

References

• WillemseBWPostmaDSTimensWten HackenNHThe impact of smoking cessation on respiratory symptoms, lung function, airway hyper-responsiveness and inflammationEur Respir J200423346447615065840
   PubMed Web of Science ®Google Scholar
• KannerREConnettJEWilliamsDEBuistASEffects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: the Lung Health StudyAm J Med1999106441041610225243
   PubMed Web of Science ®Google Scholar
• GodtfredsenNSLamTHHanselTTCOPD-related morbidity and mortality after smoking cessation: status of the evidenceEur Respir J200832484485318827152
   PubMed Web of Science ®Google Scholar
• AuDHBrysonCLChienJWThe effects of smoking cessation on the risk of chronic obstructive pulmonary disease exacerbationsJ Gen Intern Med200924445746319194768
   PubMed Web of Science ®Google Scholar
• GodtfredsenNSVestboJOslerMPrescottERisk of hospital admission for COPD following smoking cessation and reduction: a Danish population studyThorax2002571196797212403880
   PubMed Web of Science ®Google Scholar
• KupiainenHKinnulaVLLindqvistASuccessful smoking cessation in COPD: association with comorbidities and mortalityPulm Med2012201272502423213517
   PubMedGoogle Scholar
• AnthonisenNRSkeansMAWiseRAManfredaJKannerREConnettJELung Health Study Research GroupThe effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trialAnn Intern Med2005142423323915710956
   PubMed Web of Science ®Google Scholar
• MartinezFJCalverleyPMGoehringUMBroseMFabbriLMRabeKFEffect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trialLancet2015385997185786625684586
   PubMed Web of Science ®Google Scholar
• MagnussenHDisseBRodriguez-RoisinRWISDOM InvestigatorsWithdrawal of inhaled glucocorticoids and exacerbations of COPDN Engl J Med2014371141285129425196117
   PubMed Web of Science ®Google Scholar
• CalverleyPMAndersonJACelliBTORCH investigatorsSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
   PubMed Web of Science ®Google Scholar
• TashkinDPCelliBSennSUPLIFT Study InvestigatorsA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med2008359151543155418836213
   PubMed Web of Science ®Google Scholar
• TøttenborgSSThomsenRWNielsenHJohnsenSPFrausing HansenELangePImproving quality of care among COPD outpatients in Denmark 2008–2011Clin Respir J20137431932723163961
   PubMed Web of Science ®Google Scholar
• TøttenborgSSThomsenRWJohnsenSPNielsenHLangePDeterminants of smoking cessation in COPD patients treated in the outpatient settingChest2016150355456227262226
   PubMed Web of Science ®Google Scholar
• Jimenez-RuizCAMasaFMiravitllesMSmoking characteristics: differences in attitudes and dependence between healthy smokers and smokers with COPDChest200111951365137011348940
   PubMed Web of Science ®Google Scholar
• CahillKStevensSPereraRLancasterTPharmacological interventions for smoking cessation: an overview and network meta-analysisCochrane Database Syst Rev20135CD009329
   PubMed Web of Science ®Google Scholar
• TashkinDKannerRBaileyWSmoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trialLancet200135792681571157511377644
   PubMed Web of Science ®Google Scholar
• WagenaEJKnipschildPGHuibersMJWoutersEFvan SchayckCPEfficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary diseaseArch Intern Med2005165192286229216246996
   PubMedGoogle Scholar
• AnthenelliRMBenowitzNLWestRNeuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trialLancet2016387100372507252027116918
   PubMed Web of Science ®Google Scholar
• LangePTøttenborgSSSorknesADDanish register of chronic obstructive pulmondary diseaseClin Epidemiol201681626793005
   PubMed Web of Science ®Google Scholar
• KildemoesHWSorensenHTHallasJThe Danish national prescription registryScand J Public Health2011397 Suppl384121775349
   PubMed Web of Science ®Google Scholar
• LangePMarottJLVestboJPrediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general populationAm J Respir Crit Care Med20121861097598122997207
   PubMed Web of Science ®Google Scholar
• GreenlandSPearlJRobinsJMCausal diagrams for epidemiologic researchEpidemiology199910137489888278
   PubMed Web of Science ®Google Scholar
• ChristensenDHRungbyJThomsenRWNationwide trends in glucose-lowering drug use, Denmark, 1999–2014Clin Epidemiol2016838138727789974
   PubMed Web of Science ®Google Scholar
• SogaardMThomsenRWBossenKSSorensenHTNorgaardMThe impact of comorbidity on cancer survival: a reviewClin Epidemiol20135Suppl 132924227920
   PubMedGoogle Scholar
• McKeeSAO’MalleySSSaloveyPKrishnan-SarinSMazureCMPerceived risks and benefits of smoking cessation: gender-specific predictors of motivation and treatment outcomeAddict Behav200530342343515718060
   PubMed Web of Science ®Google Scholar
• AbramsDBMontiPMPintoRPElderJPBrownRAJacobusSIPsychosocial stress and coping in smokers who relapse or quitHealth Psychol1987642893033301320
   PubMed Web of Science ®Google Scholar
• PomerleauCSSmoking and nicotine replacement treatment issues specific to womenAm J Health Behav199620291299
   Web of Science ®Google Scholar
• TøttenborgSSLangePJohnsenSPNielsenHIngebrigtsenTThomsenRWSocioeconomic inequalities in adherence to inhaled maintenance medications and clinical prognosis of COPDRespir Med201611916016727692139
   PubMed Web of Science ®Google Scholar
• RedaAAKotzDEversSMvan SchayckCPHealthcare financing systems for increasing the use of tobacco dependence treatmentCochrane Database Syst Rev20126CD004305
   Google Scholar
• PisingerCAadahlMToftUJorgensenTMotives to quit smoking and reasons to relapse differ by socioeconomic statusPrev Med2011521485221047525
   PubMed Web of Science ®Google Scholar
• SchillerJSNiHCigarette smoking and smoking cessation among persons with chronic obstructive pulmonary diseaseAm J Health Promot200620531932316706002
   PubMed Web of Science ®Google Scholar
• van EerdEAMBech RisorMSpigtMWhy do physicians lack engagement with smoking cessation treatment in their COPD patients? A multinational qualitative studyNPJ Prim Care Respir Med20172714128646217
   PubMed Web of Science ®Google Scholar
• BlackstockFCZuWallackRNiciLLareauSCWhy don’t our patients with chronic obstructive pulmonary disease listen to us? The enigma of nonadherenceAnn Am Thorac Soc201613331732326882499
   PubMed Web of Science ®Google Scholar
• TottenborgSSLangePJohnsenSPNielsenHIngebrigtsenTSThomsenRWSocioeconomic inequalities in adherence to inhaled maintenance medications and clinical prognosis of COPDRespir Med201611916016727692139
   PubMed Web of Science ®Google Scholar